News & Topics

A poster presentation on drug development utilizing MA-T system (HM-001) will be presented at AACR (American Association for Cancer Research) in April 2024.

At the AACR ANNUAL MEETING to be held in San Diego, U.S. from April 5, we will present a progress report on the
drug development (HOIST Project No. HM-001) utilizing the MA-T system for the treatment of non-invasive bladder
cancer (NMIBC) in the muscle layer. Here, we will add the results of drug efficacy evaluation utilizing the PDX
(Patient-Derived Cancer Transplantation Model) and present data (poster presentation) on the expected efficacy in
low- and intermediate-risk patients, which is a large patient population among NMIBC. This evaluation system is only
available at HOIST worldwide.

AACR Annual Meeting 2024